Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

44 results
Display

Two Lung Masses with Different Responses to Pemetrexed

Park KY, Jung JW, Nam SB, Lee HJ, Kim HS, Choi YH, Lee JC

We described here a patient who had two lung masses. Although the two masses had the same histology and a similar good response to initial chemotherapy with gemcitabine and carboplatin,...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Docetaxel-Cisplatin-5-FU Combination Chemotherapy as a First-line Treatment in Patients with Metastatic or Recurred Gastric Cancer

Kim JH, Lee YC

  • KMID: 782915
  • Korean J Gastroenterol.
  • 2007 Sep;50(3):207-209.
No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Therapy-Related Acute Myeloid Leukemia Following 5-Fluorouracil Chemotherapy

Park HJ, Choi JH, Lee KA, Kim HC, Nam YS, Oh YH, Lee WS

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Recent Advances in Palliative Chemotherapy for Unresectable Pancreatic Cancer

Ryu JK

Pancreatic adenocarcinoma is one of the fatalist malignancies. A large proportion of patients are diagnosed with unresectable stage pancreatic cancer at the time of presentation. Gemcitabine is a standard chemotherapeutic...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Review of Modeling Approaches to Predict Drug Response in Clinical Oncology

Park K

Model-based approaches have emerged as important tools for quantitatively understanding temporal relationships between drug dose, concentration, and effect over the course of treatment, and have now become central to optimal...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imatinib mesylate-induced interstitial lung disease in a patient with prior history of Mycobacterium tuberculosis infection

Lee NR, Jang JW, Kim HS, Yhim HY

No abstract available.
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
High-Dose Vitamin C Promotes Regression of Multiple Pulmonary Metastases Originating from Hepatocellular Carcinoma

Seo MS, Kim JK, Shim JY

We report a case of regression of multiple pulmonary metastases, which originated from hepatocellular carcinoma after treatment with intravenous administration of high-dose vitamin C. A 74-year-old woman presented to the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Imatinib Plasma Monitoring-Guided Dose Modification for Managing Imatinib-Related Toxicities in Gastrointestinal Stromal Tumor Patients

Yoon S, Ryu MH, Yoo C, Beck MY, Ryoo BY, Kang YK

Imatinib, the first-line treatment in patients with advanced gastrointestinal stromal tumors (GIST), is generally well tolerated, although some patients have difficulty tolerating the standard dose of 400 mg/day. Adjusting imatinib...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vortex Keratopathy in a Patient Receiving Vandetanib for Non-Small Cell Lung Cancer

Ahn J, Wee WR, Lee JH, Hyon JY

We report a case of vortex keratopathy in a patient treated with vandetanib for non-small cell lung cancer (NSCLC). A 44-year-old female who underwent two cycles of chemotherapy for NSCLC...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Bi-weekly Chemotherapy of Paclitaxel and Cisplatin in Patients with Metastatic or Recurrent Esophageal Cancer

Cho SH, Chung IJ, Song SY, Yang DH, Byun JR, Kim YK, Lee JJ, Na KJ, Kim HJ

Although various combinations of chemotherapy regimens have been tried for patients with esophageal cancer, their duration of survival is extremely poor. In this study, we investigated the safety and clinical...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
External validation of chemotherapy response score system for histopathological assessment of tumor regression after neoadjuvant chemotherapy in tubo-ovarian high-grade serous carcinoma

Lee JY, Chung YS, Na K, Kim HM, Park CK, Nam EJ, Kim S, Kim SW, Kim YT, Kim HS

OBJECTIVE: The chemotherapy response score (CRS) system based on histopathological examination has been recently proposed for tubo-ovarian high-grade serous carcinoma (HGSC) to assess response to neoadjuvant chemotherapy (NAC). This study...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Pathological responses to preoperative high-dose methotrexate chemotherapy in osteosarcoma: experience in Korea cancer hospital

Lee SY, Jeon DG, Kim SS, Jang JJ, Cho KJ

During the last decade, many clinical investigators at various cancer centers have reported the efficacy of various chemotherapeutic agents in the treatment of osteosarcoma. The regimens using high-dose methotrexate (HDMTX)...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Hepatic Lesions that Mimic Metastasis on Radiological Imaging during Chemotherapy for Gastrointestinal Malignancy: Recent Updates

You SH, Park BJ, Kim YH

During chemotherapy in patients with gastrointestinal malignancy, the hepatic lesions may occur as chemotherapy-induced lesions or tumor-associated lesions, with exceptions for infectious conditions and other incidentalomas. Focal hepatic lesions arising...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A Case of Primary Adrenal Diffuse Large B-cell Lymphoma Achieving Complete Remission with Rituximab-CHOP Chemotherapy

Kim KM, Yoon DH, Lee SG, Lim SN, Sug LJ, Huh J, Suh C

Primary adrenal lymphoma is a very rare extranodal lymphoma; its clinical features consist of a high incidence of bilateral adrenal involvement and diffuse large B-cell lymphoma. We report a patient...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The effect of continuous androgen deprivation treatment on prostate cancer patients as compared with intermittent androgen deprivation treatment

Ku JY, Lee JZ, Ha HK

PURPOSE: To investigate the efficacy of androgen deprivation treatment (ADT) between continuous and intermittent ADT. MATERIALS AND METHODS: Between January 2006 and May 2015, 603 patients were selected and divided into...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Long-term outcomes of patients with advanced hepatocellular carcinoma who achieved complete remission after sorafenib therapy

Park JG

BACKGROUND/AIMS: Sorafenib is currently the sole molecular targeted agent that improves overall survival in advanced hepatocellular carcinoma (HCC). Despite the efficacy of sorafenib, the response rate varies in patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Modification of adriamycin-induced cytotoxicity by recombinant human interferon-gamma and/or verapamil in human stomach cancer cells

Hong WS, Kim CM, Lee CT, Lee JO, Kang TW

Recombinant human-interferon-gamma (rH-IFN-gamma) and verapamil (VRP), either alone or in combination, were evaluated in MTT assay for their modification effects on adriamycin-induced cytotoxicity against MKN-45, human stomach adenocarcinoma cells....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
S-1 Monotherapy as a Neoadjuvant Treatment for Locally Advanced Gastric Cancer

Jung JY, Rha SY, Ahn JB, Yang WI, Noh SH, Chung HC, Jeung HC

S-1, a novel oral fluoropyrimidine, is an effective therapeutic agent for gastric cancer. Herein, we report a case with locally advanced gastric cancer that achieved a curative resection after S-1...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Thalidomide for Treating Metastatic Hepatocellular Carcinoma: A Pilot Study

Han SH, Park SH, Kim JH, Lee JJ, Kwon SY, Kwon OS, Kim SS, Kim JH, Kim KK, Park YH, Lee JN, Nam E, Bang SM, Cho EK, Shin DB, Lee JH

BACKGROUND: Thalidomide has been reported to have antitumor activity for treating metastatic hepatocellular carcinoma (HCC). We evaluated the safety and efficacy of using thalidomide for treating selected patients with...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Toxicity Profile of Temozolomide in the Treatment of 300 Malignant Glioma Patients in Korea

Bae SH, Park MJ, Lee MM, Kim TM, Lee SH, Cho SY, Kim YH, Kim YJ, Park CK, Kim CY

This study evaluated the toxicity profiles of temozolomide in the treatment of malignant glioma as either concurrent or adjuvant chemotherapy. We retrospectively reviewed the medical records of 300 malignant glioma...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr